...
首页> 外文期刊>Pediatric Hematology and Oncology >Varicella in pediatric oncology patients in the post-vaccine eraAnalysis of routine hospital data from Bavaria (Germany), 2005-2011
【24h】

Varicella in pediatric oncology patients in the post-vaccine eraAnalysis of routine hospital data from Bavaria (Germany), 2005-2011

机译:儿科肿瘤学患者的静脉曲张疫苗患者患者的常规医院数据来自巴伐利亚(德国),2005-2011

获取原文
获取原文并翻译 | 示例

摘要

Varicella in oncology patients can result in serious complications. We analyzed trends in hospitalization rates and characteristics of pediatric oncology and non-oncology patients hospitalized with varicella during the first 7years after introduction of routine varicella vaccination. Our data included children <17years of age with an International Classification of Diseases and Related Health Problems, 10th Revision (ICD-10) main or secondary discharge diagnosis of varicella identified by annual database queries in 22-29 pediatric hospitals in Bavaria (Germany) in 2005-2011. Of a total of 1,245 varicella-associated hospitalizations, 42 children (median age 4years, interquartile range 3-5) had an underlying malignancy (67% with acute lymphoblastic leukemia). Overall, additional diagnoses potentially associated with varicella were reported less often in oncology than in non-oncology varicella patients (62% vs. 77%, p = 0.041), suggesting earlier hospitalization of high-risk patients. Acute hematological diagnoses (29% vs. 3%, p <0.001) and coinfections (invasive 12% vs. 2%, p = 0.001; noninvasive 19% vs. 8%, p = 0.019) were more frequent, whereas neurological (5% vs. 19%, p = 0.023) and upper respiratory tract diagnoses (2% vs. 16%, p = 0.014) were less frequent in oncology compared to non-oncology varicella patients. Oncology varicella patients showed a longer hospital stay (median 5vs. 3days, p<0.001). Hospitalization rates in non-oncology varicella patients declined constantly since 2006, from 114.8 (2006) to 30.5 (2011) per 1,000 pediatric beds. The rates of varicella-associated hospitalizations in oncology patients indicated an overall decreasing trend (3.8, 1.9, 4.6, 3.5, 0.4, 2.1 and 0.6 cases per 1,000 pediatric beds in 2005-2011). Thus, pediatric oncology patients potentially profit from herd protection effects, resulting from increasing vaccine coverage in the general population.
机译:肿瘤学患者的水痘可能导致严重的并发症。在引进常规瓦里氏菌疫苗接种后,我们分析了在前7只患者期间住院儿科肿瘤和非肿瘤学患者的住院率和特征的趋势。我们的数据包括儿童<17年代年龄,具有国际疾病和相关健康问题的国际分类,第10次修订(ICD-10)主要或二次放电诊断由22-29位巴伐利亚(德国)的22-29家儿科医院的年度数据库查询所识别的水痘2005-2011。共有1,245个相关的住院住院,42名儿童(中位年龄4年龄,四分位数3-5)具有潜在的恶性肿瘤(67%,急性淋巴细胞白血病)。总体而言,在肿瘤学中,肿瘤潜在的额外诊断潜在地报告肿瘤学较少,而不是在非肿瘤学变异乳液(62%与77%,P = 0.041)中,表明高危患者早期住院治疗。急性血液学诊断(29%vs.3%,P <0.001)和辛纤维(侵袭性12%vs.2%,P = 0.001;非侵入性19%,P = 0.019)更频繁,而神经系统(5与非肿瘤学改虫菌患者相比,%vs.19%,P = 0.023)和上呼吸道诊断(2%vs.16%,P = 0.014)。肿瘤学水痘患者表现出较长的住院住宿(中位数5Vs。3天,P <0.001)。自2006年以来,非肿瘤术中患者的住院率在2006年以来,从114.8(2006)到每1,000张儿科床上的30.5(2011)。肿瘤学患者中的水痘相关住院率表明2005 - 2011年每1,000张儿科床的总体下降趋势(3.8,1.9,4.6,3.5,0.4,2.1和0.6例)。因此,儿科肿瘤学患者可能从畜群保护效果中获利,从而提高了一般人群的疫苗覆盖率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号